Thiocolchicoside is NOT indicated for epigastric pain
Thiocolchicoside is a muscle relaxant specifically indicated for musculoskeletal pain and muscle spasms, not for gastrointestinal symptoms like epigastric pain. The FDA labeling indicates its use is for "symptomatic treatment of molluscum contagiosum" and "polypi and naevi symptom relief" 1, which are dermatological conditions, not gastrointestinal disorders.
Why This Drug is Inappropriate for Epigastric Pain
Mechanism of Action Mismatch
Thiocolchicoside works as a GABA-A and glycine receptor antagonist, producing muscle relaxation through spinal mechanisms 2. This mechanism has no relevance to the pathophysiology of epigastric pain, which typically involves:
- Acid-related mechanisms (peptic ulcer, gastritis, GERD)
- Visceral hypersensitivity
- Gastric dysmotility
- H. pylori infection
Evidence Base is for Musculoskeletal Conditions Only
All clinical trials of thiocolchicoside have evaluated acute low back pain and musculoskeletal disorders 3, 4, 5. A 2024 systematic review found that even for its intended use in low back pain, the clinical benefit was minimal (below the minimally important difference) with very low certainty of evidence 3.
Significant Safety Concerns
The European Medicine Agency has raised serious safety concerns about thiocolchicoside 3. Documented adverse effects include:
- Liver injury and pancreatitis
- Seizures
- Blood cell disorders
- Genotoxicity and teratogenicity
- Altered spermatogenesis including azoospermia
- Rhabdomyolysis 6
These risks are completely unjustified when treating epigastric pain, for which effective and safer alternatives exist.
What SHOULD Be Used for Epigastric Pain
First-Line Approach
For epigastric pain (ulcer-like dyspepsia), the evidence-based treatment algorithm is 7:
Test for H. pylori in patients with symptoms >4 weeks
- Treat if positive with eradication therapy
Full-dose PPI therapy (e.g., omeprazole 20 mg once daily)
- This is the first-choice therapy for epigastric pain
- Confirms acid-related nature of symptoms if effective 7
Antispasmodics may be considered for global symptoms and abdominal pain, though evidence is limited 8
Second-Line for Refractory Pain
If symptoms persist despite PPI therapy 9, 8, 10:
Tricyclic antidepressants (amitriptyline or nortriptyline)
- Start 10 mg at night
- Titrate by 10 mg weekly to maximum 30-50 mg
- Most effective gut-brain neuromodulator for visceral pain
- Ranked first for abdominal pain in network meta-analyses 10
SNRIs (duloxetine) as alternative
- Start 30 mg once daily
- Titrate to 60 mg based on response 10
Critical Pitfall to Avoid
Never use opioid analgesics for chronic visceral abdominal pain 11. They:
- Further delay gastric emptying
- Increase risk of narcotic bowel syndrome
- Create potential for addiction and overdose
- Are completely ineffective for functional GI pain
Bottom Line
Thiocolchicoside has no role in managing epigastric pain. Use PPIs as first-line therapy, and reserve tricyclic antidepressants for refractory cases. The safety profile of thiocolchicoside makes it inappropriate even if there were theoretical benefit, which there is not.